Sign up


Match Document Document Title
US20120216678 ABSORBENT COMPOSITION AND PROCESS FOR REMOVING CO2 AND/OR H2S FROM A GAS COMPRISING CO2 AND/OR H2S  
An absorbent composition for removing CO2 and/or H2S from a gas comprising a polyamine, a monoamine and water, wherein the polyamine comprises a polyamine having 3 to 5 amine functions and has a...
US20110245444 TRANSFORMATION OF BIOMASS  
A method for processing biomass comprising heating an aqueous slurry comprising biomass, water and a phosphate catalyst in a pressure vessel at a temperature of about 150° C. to about 500° C. to p...
US20140194605 SERS Reporter Molecules and Methods  
A SERS tag comprising a core comprising at least two aggregated particles of a SERS enhancing material wherein the contact point between the particles defines a crevice; and a reporter molecule...
US20120156491 SERS Reporter Molecules and Methods  
A SERS tag comprising a core comprising at least two aggregated particles of a SERS enhancing material wherein the contact point between the particles defines a crevice; and a reporter molecule...
US20110021829 SYTNHESIS OF IODIXANOL IN METHANOL  
This invention relates to the synthesis of iodixanol (1,3-bis(acetamido)-N,N′-bis[3,5-bis(2,3-dihydroxypropylam inocarbonyl)-2,4,6-triiodophenyl]-2-hydroxypropane), more specifically to the d...
US20140012032 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS  
This invention relates to methods, which provide access to F-18 labeled stilbene derivatives.
US20140080701 Composition comprising a pesticide and an alkoxylate of 2-propylheptylamine  
The present invention relates to a composition comprising a pesticide and an alkoxylate. Moreover, the invention relates to the alkoxylate, to a process for its preparation and to its use as...
US20110201497 Composition Comprising A Pesticide and an Alkoxylate of Iso-Heptadecylamine  
The present invention relates to a composition comprising a pesticide and an alkoxylate. Moreover, the invention relates to the alkoxylate, to a process for its preparation and to its use as...
US20110177945 Composition comprising a pesticide and an alkoxylate of 2-propylheptylamine  
The present invention relates to a composition comprising a pesticide and an alkoxylate. Moreover, the invention relates to the alkoxylate, to a process for its preparation and to its use as...
US20120022027 SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES  
Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel semicarbazides, sulfonyl carbazides, ureas and related compounds in therapeutically...
US20130267482 ALPHA HELIX MIMETICS AND METHODS RELATING THERETO  
Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating...
US20130066112 MULTI-AMINE FUNCTIONAL OLIGOMERS AND METHOD FOR PRODUCING THE SAME BY THE REDUCTION OF CORRESPONDING OXIMES  
The invention relates to multi-amine functional oligomers and multi-oxime functional oligomers in addition to a method for producing the same by means of the co-polymerisation of carbonyl carriers...
US20110118505 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses  
Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides, ureas and related...
US20080293680 Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II  
The invention relates to a compound of the formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and R8 are defined as in the specification and claims and to its use for treating or preventing...
US20130296610 CHEMICAL REACTOR HAVING WOVEN WIRE MESH PRODUCT AS A RETAINING DEVICE FOR PARTICLES  
In a chemical reactor for heterogeneously catalysed reaction of a fluid, comprising a holding device for catalyst particles and/or inert particles (80, 100) through which the fluid flows, the side...
US20110064804 Methods and Compositions for the Treatment of CNS-Related Conditions  
The present invention provides novel methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions...
US20110236313 HUMAN SALTY TASTE RECEPTOR AND METHODS OF MODULATING SALTY TASTE PERCEPTION  
Methods for identifying modulators of the epithelial sodium ion channel and for identifying modulators of salty taste perception are described. Also featured are isolated human salty taste...
US20120138859 Ionic Liquid Monopropellant Gas Generator  
An energetic ionic liquid catalytic decomposition gas generator uses stoichiometric and nonstoiciometric mixtures of specific energetic ionic liquids and iridium catalyst. The catalyst temperature...
US20120157675 PURIFICATION OF TERTIARY FORMAMIDE CONTAMINATED WITH TERTIARY ACETAMIDE  
A chlorinating agent such as a chloroiminium species is used to remove or neutralize tertiary acetamide present as a contaminant in a tertiary formamide solvent. Tertiary formamide solvent purified...
US20110288101 SURGICAL COMPOSITIONS CONTAINING SIGMA-RECEPTOR AGONISTS  
One aspect of the present invention relates to aqueous surgical compositions comprising a sigma-1 receptor agonist. Another aspect of the present invention relates to methods of irrigating ocular...
US20110021634 PROCESSES FOR PREPARING METFORMIN HYDROCHLORIDE  
A process for reducing dimethylamine content in metformin hydrochloride is disclosed. The process comprises: (a) providing metformin hydrochloride having dimethylamine content more than 15 ppm;(b)...
US20130253142 SEPARATING AGENT FOR PROTEIN PURIFICATION AND PROTEIN PURIFICATION METHOD  
A novel separating agent for protein purification which not only can adsorb proteins in a sufficient amount for protein purification from a low concentration buffer but also can desorb the adsorbed...
US20130023697 METHOD FOR PRODUCING OXIME  
This invention relates to a process for producing an oxime comprising reacting a ketone and hydroxylamine in the presence of a carboxylic acid and/or its salt in a system consisting of an aqueous...
US20140081045 METAL PLATING COMPOSITIONS AND METHODS  
Disclosed are metal plating compositions and methods. The metal plating compositions provide good leveling performance and throwing power.
US20110318479 METAL PLATING COMPOSITIONS AND METHODS  
Disclosed are metal plating compositions and methods. The metal plating compositions provide good leveling performance and throwing power.
US20110039866 SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS  
Described herein are compounds useful as antagonists of sphingosine-1-phosphate receptors. Further described herein is the use of these compounds and related pharmaceutical compositions to treat...
US20140171320 Composition Comprising A Pesticide And An Alkoxylate Of 2-Isopropyl-5-Methylhexane-1-Amine  
The present invention relates to a composition comprising a pesticide and an alkoxylate. The invention further relates to the alkoxylate, to a method for the production thereof and to the use...
US20110218312 METHOD FOR PRODUCING N-ISOPROPYL(METH)ACRYLAMIDE  
A novel process is described which allows N-isopropyl(meth)acrylamide to be obtained in high purity and yield in a simple manner, by reacting methacrylic anhydride with isopropylamine, optionally...
US20120034464 DIAMOND PARTICLES HAVING ORGANIC COMPOUNDS ATTACHED THERETO, COMPOSITIONS THEREOF, AND RELATED METHODS  
A substance includes diamond particles having a maximum linear dimension of less than about 1 μm and an organic compound attached to surfaces of the diamond particles. The organic compound may ...
US20110257386 ISOLATION OF NUCLEIC ACID  
A method for isolating a nucleic acid comprises: binding the nucleic acid to a solid phase at a first pH in the presence of a binding buffer, washing the bound nucleic acid with a wash solution,...
US20100047360 Use Of Polyamines In The Treatment Of Psoriasis  
The present invention provides unbranched aliphatic polyamines for use in therapy, particularly for use in the treatment of psoriasis and compositions containing polyamines.
US20120244627 Methods for Quantifying Vitamin D Metabolites by Mass Spectrometry  
Provided are methods of detecting the presence or amount of a dihydroxyvitamin D metabolite in a sample using mass spectrometry. The methods generally comprise associating an amine with a...
US20120302794 Derivatives of venlafaxine and methods of preparing and using the same  
Methods of preparing, and compositions comprising, derivatives of venlafaxine are disclosed. Also disclosed are methods of treating and preventing diseases and disorders including, but not limited...
US20130165527 Method for Administering an NMDA Receptor Antagonist to a Subject  
Compositions and methods for administering memantine to a subject are provided. In particular, a solid pharmaceutical composition in a unit dosage form for once daily oral administration is...
US20120178747 Compositions and methods for bone formation and remodeling  
The mechanism by which the high bone mass (HBM) mutation (G171V) of the Wnt coreceptor LRP5 regulates the canonical Wnt signaling was investigated. The mutation was previously shown to reduce Dkk...
US20100298308 Compositions and methods for bone formation and remodeling  
The mechanism by which the high bone mass (HBM) mutation (G171V) of the Wnt coreceptor LRP5 regulates the canonical Wnt signaling was investigated. The mutation was previously shown to reduce Dkk...
US20100324064 NOVEL ANALOGS OF CHOLINE FOR NEUROPROTECTION AND COGNITIVE ENHANCEMENT IN NEURODEGENERATIVE DISORDERS  
The present invention relates to novel analogs of choline and methods of use or treatment of neurodegenerative disorders and/or conditions such as Parkinson's disease, Huntington disease,...
US20140206903 NOVELCROSSLINKING REAGENTS, MACROMOLECULES, THERAPEUTIC CONJUGATES, AND SYNTHETIC METHODS THEREOF  
The invention provides novel chemical entities based on sugar alcohols. These new chemical entities are biocompatible and biodegradable. The molecules can be made in a single and pure form. The...
US20110046138 NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS  
A series of novel compounds showing anticonvulsant activity is described. Such pharmaceutically active compounds may also show utility in the treatment of other central nervous system (“CNS”) dis...
US20140200324 PRODUCTION OF POLYOLS USING DISTILLERS GRAINS AND PROTEINS AND LIGNIN EXTRACTED FROM DISTILLERS GRAINS  
Processes for the production of polyols from sources such as dried distillers grains plus solubles (DDGS) make use of a two-stage reaction scheme. In the first stage, the proteinaceous starting...
US20110290418 HYDROGEN PEROXIDE COMPLEXES AND THEIR USE IN THE CURE SYSTEM OF ANAEROBIC ADHESIVES  
Provided is a complex of hydrogen peroxide and at least one compound represented by Formula I: wherein X is: —C(R3)3, —C≡C(R3), —O(R3), —N(R3)2, or —S(R3); and R1, R2, and R3 are each independent...
US20140087005 MODULATORS OF HSP70/DNAK FUNCTION AND METHODS OF USE THEREOF  
Compositions and methods for modulating HSP70 function, particularly for the targeted killing of cancer cells, are disclosed.
US20110189125 Modulators of HSP70/DnaK Function and Methods of Use Thereof  
Compositions and methods for modulating HSP70 function, particularly for the targeted killing of cancer cells, are disclosed.
US20110021827 CRYSTALLIZATION OF IODIXANOL USING ULTRASOUND  
This invention relates to the manufacture of iodixanol (1,3-bis(acetamido)-N,N′-bis[3,5-bis (2,3-dihydroxypropylaminocarbonyl)-2,4,6-triiodophenyl]-2-hy droxypropane), more specifically to the p...
US20130217778 METHODS AND COMPOSITIONS FOR THE IMPROVEMENT OF SKELETAL MUSCLE FUNCTION IN A MAMMAL  
The present invention is directed to the treatment of muscular dysfunction or increasing muscle strength and/or decreasing muscle fatigue in a subject using a composition that includes a biguanide...
US20100051879 Functionalized Boron Nitride Nanotubes  
A plasma treatment has been used to modify the surface of BNNTs. In one example, the surface of the BNNT has been modified using ammonia plasma to include amine functional groups. Amine...
US20140135529 METHOD FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT  
Compositions and methods for administering memantine to a subject are provided. In particular, a solid pharmaceutical composition in a unit dosage form for once daily oral administration is...
US20130231326 SELECTIVE SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS  
Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds...
US20130196966 SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS  
Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds...
US20110172202 SELECTIVE SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS  
Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds...